Switch theme
Sign up to access all valuation multiples
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has three operating segments being the hospitals business, Vita Health Group and The Doctors Clinic Group. The company has aggregated Vita Health Group and The Doctors Clinic Group into one reportable segment called primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery.
2014
15.7K+
LTM Revenue $2.1B
LTM EBITDA $358M
$2.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Spire Healthcare Group has a last 12-month revenue (LTM) of $2.1B and a last 12-month EBITDA of $358M.
In the most recent fiscal year, Spire Healthcare Group achieved revenue of $2.0B and an EBITDA of $334M.
Spire Healthcare Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Spire Healthcare Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | XXX | $2.0B | XXX | XXX | XXX |
| Gross Profit | $856M | XXX | $918M | XXX | XXX | XXX |
| Gross Margin | 41% | XXX | 45% | XXX | XXX | XXX |
| EBITDA | $358M | XXX | $334M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| EBIT | $207M | XXX | $190M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $49.1M | XXX | $34.1M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $438M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Spire Healthcare Group's stock price is GBP 2 (or $3).
Spire Healthcare Group has current market cap of GBP 778M (or $1.0B), and EV of GBP 2.0B (or $2.7B).
See Spire Healthcare Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.7B | $1.0B | XXX | XXX | XXX | XXX | $0.12 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Spire Healthcare Group has market cap of $1.0B and EV of $2.7B.
Spire Healthcare Group's trades at 1.3x EV/Revenue multiple, and 8.1x EV/EBITDA.
Equity research analysts estimate Spire Healthcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Spire Healthcare Group has a P/E ratio of 21.3x.
See valuation multiples for Spire Healthcare Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
| EV (current) | $2.7B | XXX | $2.7B | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 7.6x | XXX | 8.1x | XXX | XXX | XXX |
| EV/EBIT | 13.0x | XXX | 14.3x | XXX | XXX | XXX |
| EV/Gross Profit | 3.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 21.3x | XXX | 30.6x | XXX | XXX | XXX |
| EV/FCF | 19.9x | XXX | 16.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSpire Healthcare Group's last 12 month revenue growth is 6%
Spire Healthcare Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $46K for the same period.
Spire Healthcare Group's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Spire Healthcare Group's rule of X is 31% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Spire Healthcare Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 31% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $46K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 36% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Spire Healthcare Group acquired XXX companies to date.
Last acquisition by Spire Healthcare Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Spire Healthcare Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Spire Healthcare Group founded? | Spire Healthcare Group was founded in 2014. |
| Where is Spire Healthcare Group headquartered? | Spire Healthcare Group is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Spire Healthcare Group have? | As of today, Spire Healthcare Group has 15.7K+ employees. |
| Who is the CEO of Spire Healthcare Group? | Spire Healthcare Group's CEO is Mr. Justinian Joseph Ash. |
| Is Spire Healthcare Group publicy listed? | Yes, Spire Healthcare Group is a public company listed on LON. |
| What is the stock symbol of Spire Healthcare Group? | Spire Healthcare Group trades under SPI ticker. |
| When did Spire Healthcare Group go public? | Spire Healthcare Group went public in 2014. |
| Who are competitors of Spire Healthcare Group? | Similar companies to Spire Healthcare Group include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Spire Healthcare Group? | Spire Healthcare Group's current market cap is $1.0B |
| What is the current revenue of Spire Healthcare Group? | Spire Healthcare Group's last 12 months revenue is $2.1B. |
| What is the current revenue growth of Spire Healthcare Group? | Spire Healthcare Group revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Spire Healthcare Group? | Current revenue multiple of Spire Healthcare Group is 1.3x. |
| Is Spire Healthcare Group profitable? | Yes, Spire Healthcare Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Spire Healthcare Group? | Spire Healthcare Group's last 12 months EBITDA is $358M. |
| What is Spire Healthcare Group's EBITDA margin? | Spire Healthcare Group's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Spire Healthcare Group? | Current EBITDA multiple of Spire Healthcare Group is 7.6x. |
| What is the current FCF of Spire Healthcare Group? | Spire Healthcare Group's last 12 months FCF is $136M. |
| What is Spire Healthcare Group's FCF margin? | Spire Healthcare Group's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Spire Healthcare Group? | Current FCF multiple of Spire Healthcare Group is 19.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
